Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis (Q34753785)

4 August 2017

1 reference

title

Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis (English)

1 reference

4 August 2017

Perazella MA

1

1 reference

4 August 2017

Mahnensmith RL

series ordinal

2

1 reference

4 August 2017

publication date

1 October 1997

1 reference

Journal of General Internal Medicine

4 August 2017

published in

1 reference

4 August 2017

volume

12

1 reference

4 August 2017

issue

10

1 reference

4 August 2017

page(s)

646-656

1 reference

https://scigraph.springernature.com/pub.10.1046/j.1525-1497.1997.07128.x

4 August 2017

exact match

0 references

cites work

Hyperkalemia in the elderly

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Brief report: trimethoprim-induced hyperkalemia in a patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Trimethoprim-sulfamethoxazole induces reversible hyperkalemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Renal mechanism of trimethoprim-induced hyperkalemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Aging as a factor in the renal hemodynamic changes induced by a standardized pyrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Senescence and the renal vasculature in normal man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Renal vasodilatory response to intravenous glycine in the aging rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Longitudinal studies on the rate of decline in renal function with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Effects of aging on the renal glomerulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Intrarenal vascular changes with age and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

The Effect of Age on Creatinine Clearance in Men: A Cross-sectional and Longitudinal Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Hyperkalemia and hyporeninemic hypoaldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Reduced thirst after water deprivation in healthy elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Hyperkalaemic paralysis due to spironolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Possible predisposition of diabetic patients to hyperkalemia following administration of potassium-retaining diuretic, amiloride (MK 870)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Moduretic-induced metabolic acidosis and hyperkalaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Renal complications of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Renal syndromes associated with nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Indomethacin-induced hyperkalemia in three patients with gouty arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Piroxicam-induced renal failure and hyperkalemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Reversible acute renal insufficiency and hyperkalemia following indomethacin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Heparin-induced aldosterone suppression and hyperkalemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Suicidal and accidental digoxin ingestion. Report of five cases with serum digoxin level correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Massive intravenous digoxin overdosage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Stimulation of Na:H exchange by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Active Na-K transport and the rate of ouabain binding. The effect of insulin and other stimuli on skeletal muscle and adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Nebulized albuterol for acute hyperkalemia in patients on hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

A comparison of the extent and duration of hypokalaemia following three nebulized beta 2-adrenoceptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Bicarbonate in the treatment of severe hyperkalemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Effect of potassium removal during hemodialysis on the plasma potassium concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

Drug attributed alterations in potassium handling in congestive cardiac failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1997.07128.X

10.1046/J.1525-1497.1997.07128.X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference